Procurement Summary
Country : Brazil
Summary : Pricing Registration Intent for Future and Eventual Acquisition of Medicines (Various) 05 (For the Items: 01, 04 and 14, the Descriptions Made Available in Net Purchases Differ from the Reference Term, ...
Deadline : 25 Apr 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 117364874
Document Ref. No. : 91122/2024
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Intent of Price Registration for Future and Eventual Acquisition of Medicines (Miscellaneous) 05 (For the items: 01, 04 and 14, the descriptions available in NET purchases differ from the reference term, consider for the presentation of the items the reference term of this event, As published in the warning board).
UASG Code: 925998
Notice from: 07/04/2025 from 08:00 to 14:00 hs
Delivery of the proposal: from 07/04/2025 to 08:00
Isoflurane, Inhaling Presentation
Quantity: 12
Mebendazole, dosage 20 mg/ml: 15
Myconazole Nitrate, dosage 20 mg/g, presentation Cream
Quantity: 250
Multivitamines, Vitamin Composition Vitamins: A, B1, B2, B3, B5, B6, C, D, E, Biotin Amino Acid Composition, Pharmaceutical Form 1 Oral Solution
Quantity
Nimesulide, dosage 50 mg/ml, Drops
Quantity: 112
Zinc oxide, active ingredient associated with vitamin A + vitamin D, dosage150mg + 5.000UI + 900UI/g, Ointment Presentation
Quantity: 778
Periciazine, dosage 40 mg/mL, pharmaceutical form oral-drops
quantity: 480
petrolate, pure concentration, pharmaceutical formOintment
Quantity: 64
Polymicixin B, composition associated with neomycin and hydrocortisone, concentration 10, 000 IU/ml/ml/ml + 10 mg/ml, pharmaceutical form otological suspension
quantity: 52
salbutamol, dosage 0.4 mg/ml, pharmaceutical form xarope
quantity, ferrous sulfate, iron dosage iron dosage25mg/ml of iron II, pharmaceutical form solution-Gotter
Quantity: 280
tobramicin, active ingredient associated with dexamethasone, dosage 0.3% + 0.1%, ointment ointment presentation
Quantity: 10
chlorhexidine diglucanato, dosage 2%, application topical solution
quantity
quantity, Presentation aqueous solution, concentration 50%
Quantity: 72000 ...
Documents
Tender Notice